Bar Partners brings bars to life with no-cost games and photo booths, creating new revenue streams from day one. Founded in Austin, Texas, the company now operates in all 50 states thanks to its ...

In July 2025, we closed the acquisition of Globetopper, adding $60–$70 million in annual revenue and positive EBITDA. This acquisition also kickstarted the relaunch of our fintech division, and we ...

A heavy slate of earnings is on deck this week, led by tech titans and major U.S. corporations. Tesla (NASDAQ:TSLA) and Alphabet (NASDAQ:GOOGL) will be in the spotlight, with reports from Intel ...

Silence was often a strategic choice, with many leaders staying mum due to fear of retaliation. The evidence also suggested ...

Verizon's Q2 beat expectations, but weak growth, rising debt from the $20B Frontier deal, and minimal EPS guidance spark ...

Verizon trades at just 9x earnings with a 6.3% yield, poised for upside from AI, 5G, and dividend growth potential. Find out ...

Verizon continued to gain broadband market share, reporting 293,000 broadband net additions during the quarter. Fixed ...

Bosses aren’t just unapologetic about staff cuts. Many are touting shrinking head counts as accomplishments in the AI era.

The Mobile Networks division, home to Nokia’s radio access network (RAN) portfolio, used to be vendor’s crown jewelNow the vendor’s Network Infrastructure ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

CEO Hans Vestberg stated on Monday that the company is increasing its full-year free cash flow forecast. “We're also raising ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, named director Kirk Perry as interim chief executive officer as Thibaut Mongon departs the company.